NCT01313637 · Interventional trial
A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD
Overall registry status Completed
Phase 3
Conditions Pulmonary Disease, Chronic Obstructive
Delaware Valley sites
- GSK Investigational Site · Cherry Hill, NJ · Camden County
First posted
Registry updated
Added to the directory